Cyclacel Pharmaceuticals (CYCC) Q3 2024 Earnings

14AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-6.23
-4.27
-2.32
-0.36

Details

Expected EPS
-1.435
Actual EPS
-0.72
Surprise EPS
0.72
Surprise Percent
+49.83%

Description

Cyclacel Pharmaceuticals (CYCC) has reported earnings of -0.72 per share for Q3 2024.

0 Comments

Share your thoughts